STAU2-AS1

Across TCGA pan-cancer cohorts, STAU2-AS1 RNA differs between tumor and matched normal tissue in 12 of 18 cancer types tested, making tumor–normal expression one of STAU2-AS1’s most consistent transcriptional readouts.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where STAU2-AS1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types STAU2-AS1 is over-expressed in tumor, although a few such as HNSC and READ show the opposite, repressed pattern.

LIHC, LUAD, and UCEC are the cancer types where STAU2-AS1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in STAU2-AS1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LIHC	Male	II,III,IV	+0.304	<.001	9	view →
LUAD	All	All	+0.388	<.001	7	view →
UCEC	All	All	+0.528	<.001	6	view →
LUSC	All	All	+0.278	<.001	4	view →
STAD	All	All	+0.181	.015	4	view →
HNSC	All	All	−0.156	.016	4	view →
BRCA	All	All	+0.124	.015	4	view →
KIRC	Female	IV	+0.283	.009	3	view →
PAAD	Male	All	+0.360	.037	2	view →
CHOL	All	All	+0.295	.009	2	view →
READ	All	All	−0.168	.031	1	view →
COAD	All	IV	−0.155	.040	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 12 lineages.

STAU2-AS1–LIHC

Open the LIHC breakdown →